- Home
- PIII vs IRIX Comparison
PIII vs IRIX Comparison
Compare PIII & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PIII | IRIX |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 20.2M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PIII | IRIX |
|---|---|---|
| Price | $4.21 | $1.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.25 | N/A |
| AVG Volume (30 Days) | 10.7K | ★ 63.0K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,444,952,000.00 | $50,647,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | $12.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $4.01 | $0.78 |
| 52 Week High | $14.50 | $1.89 |
Technical Indicators
Market Signals| Indicator | PIII | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 21.04 | 54.22 |
| Support Level | $5.01 | $0.95 |
| Resistance Level | $5.20 | $1.07 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 2.48 | 61.52 |
Price Performance
Historical ComparisonAbout PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.